Feyza İNCİ, Varlık DOĞAN, Zeynep ETİ, Mustafa DENİZ, Yılmaz GÖĞÜŞ

The effects of dexmedetomidine infusion on the formation of reactıve oxygen species during mesenterıc ischemia-reperfusion injury in rats

Amaç: bu çalışmanın amacı; sıçanlarda oluşturulan mezenter iskemi-reperfüzyon modelinde intravenöz uygulanan deksmedetomidinin reaktif oksijen ürün düzeyi üzerine etkilerinin araştırılmasıdır. Metod: 300-320 g ağırlığında, 28 adet, erkek, Spraque-Dawley cinsi sıçan dört gruba ayrıldı (n:7). Sham operasyonu geçiren iki gruptan; grup 1’deki sıçanlara (Kontrol grup, Grup K) ilaç uygulanmazken grup 2’deki sıçanlara 5 mg/kg/s deksmedetomidin infüzyonu yapıldı. Diğer iki gruba (grup 3 ve 4) süperior mezenter arter ligasyonu ile 30 dk iskemi ve ardından 60 dk reperfüzyon uygulandı (I/R). İskemi-reperfüzyon sırasında Grup 3’deki (I/R-S) sıçanlara 0.9% NaCl ve grup 4’deki (I/R-D) sıçanlara 5 mg/kg/h deksmedetomidin infüzyonu yapıldı. İleumdan, luminal ve lusigenin kemiluminesans (KL), doku miyeloperoksidaz aktivitesi, malondialdehid (MDA) ve glutatyon seviyesi ölçümleri için doku örnekleri alındı. Bulgular: Luminol KL seviyesi, doku miyeloperoksidaz aktivitesi (p

Deksmedetomidin infüzyonunun sıçanlarda mezenter iskemi-reperfüzyon hasarında oluşan reaktif okisjen türleri üzerine etkisi

Objective: The aim of this study was to evaluate the effect of dexmedetomidine infusion on the formation of reactive oxygen species during mesenteric ischemia-reperfusion injury in rats. Methods: Twenty-eight male Sprague-Dawley rats weighing between 300-320 g were divided into four groups (n=7). The first two groups underwent sham operation; group 1 was the control group and group 2 received 5 µg/kg/h dexmedetomidine iv infusion. Ischemia-reperfusion (I/R) was produced in the remaining two groups (group 3 and 4) by ligation of the superior mesenteric artery for 30 min followed by 60 min of reperfusion period. Group 3 (I/R-S) rats were control I/R rats receiving 0.9% NaCl infusion and group 4 (I/R-D) rats received 5 µg/kg/h dexmedetomidine iv infusion during I/R. Tissue samples were obtained from the ileum for the measurement of luminol and lucigenin enhanced chemiluminescence (CL), tissue myeloperoxidase activity, malondialdehyde (MDA) and glutathione levels. Results: Luminol CL levels, tissue myeloperoxidase activity (p<0.001) and MDA levels (p<0.05) were significantly higher in I/R-S group compared with sham-operated groups and I/R-D group. Glutathione levels of I/R-S group was significantly higher than those of I/R-D group (p<0.05). Conclusion: We concluded that dexmedetomidine infusion can prevent the increase in reactive oxygen species during mesenteric ischemia-reperfusion injury in rats.

PDF

___

1) McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-63.
2) Stefanutti G, Vejchapipat P, Williams SR, Pierro A, Eaton S. Heart energy metabolism after intestinal ischaemia and reperfusion. J Pediatr Surg 2004; 39: 179-83.
3) Stoney RJ, Cunninghan CG. Acute mesenteric ischemia. Surgery 1993; 114: 489-90.
4) Grace PA. Ischaemia-reperfusion injury. Br J Surg 1994; 81: 637-47.
5) Kharbanda RK, Peters M, Walton B et al. Ischemic preconditioning prevents endothelial injury and systemic activation during ischemia-reperfusion in humans in vivo. Circulation 2001; 103: 1624-30.
6) Bhaskar L, Mathan MM, Balasubramanian KA. Oxygen free radical-induced damage during colonic ischemia/reperfusion in rats. Mol Cell Biochem 1995; 151 (1): 9-14.
7) Reichhalter R, Lillie C, Kobinger W. Effects of alinidine on survival and infarct size in rats with coronary artery occlusion. Eur J Pharmacol 1988; 157: 75-81.
8) Cai JJ, Morgan DA, Haynes WG, Martins JB, Lee HC. á2-adrenergic stimulation is protective against ischemia-reperfusion-induced ventricular arrhythmias in vivo. Am J Physiol Heart Circ Physiol 2002; 283: 2606-2611.
9) Yuan SZ, Runold M, Hagberg H, Bona E, Lagercrantz H. Hypoxic-ischaemic brain damage in immature rats: effects of adrenergic modulation. Eur J Paed Neurol 2001; 5: 29-35.
10) Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specifity and potency of medetomidine as an á2-adrenoceptor agonist. Eur J Pharmacol 1988; 150: 9-14.
11) Kuhmonen J, Haapalinna A, Sivenius J. Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat. J Neural Transm 2001; 108: 261-271.
12) Jolkkonen J, Puurunen K, Koistinaho JR et al. Neuroprotection by the á2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia. Eur J Pharmacol 1999; 372: 31-36.
13) Nacif-Coelho C, Correa-Saler C, Chang LL, Maze M. The hypnotic response to the á2-adrenoceptor agonist, dexmedetomidine in the locus coeruleus of the rat. Anesthesiology 1994; 81: 1527-34.
14) Surprenant A, Horstman DA, Akbarali H, Limbird LE. A point mutation of the á2-adrenoceptor that blocks coupling to potassium but not calcium currents. Science 1992; 257: 977-80.
15) Vulliemoz Y, Shen H, Virag I. á2 Adrenoceptor agonists decrease cyclic guanosine 3’5’ monophosphate in the mouse brain. Anesthesiology 1996; 85: 544-50.
16) Talke P, Bickler PE. Effects of dexmedetomidine on hypoxia-evoked glutamate release and glutamate receptor activity in hippocampal slices. Anesthesiology 1996; 85: 551-7.
17) Matsumato M, Zornow MH, Rabin BC, Maze M. The á2-adrenergic agonist, dexmedetomidine, selectively attenuates ischemia-induced increases in striatal norepinephrine concentrations. Brain Res 1993; 627: 325-29.
18) Engelhard K, Werner C, Kaspar S et al. Effect of the a2-agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesthesiology 2002; 96: 450-57.